Highlights

• Chinese rare earth company Zhongke claims a breakthrough lighting technology using special phosphor materials can slow myopia progression in children, backed by decade-long research on juvenile macaques published in Zoological Research.
• The “rare-earth photobiological axial-inhibition technology” uses 3000K low-color-temperature light with a specific B/M spectrum to inhibit excessive eye-axis growth, moving beyond lab testing to deployment in multiple Chinese schools.
• While representing China’s push for higher-value rare earth applications in consumer health products, the technology lacks peer-reviewed human trial data, control-arm details, and long-term safety verification for Western validation.

---

A Chinese rare earth materials company says it has developed a lighting technology designed to slow the progression of myopia, or nearsightedness, in children and teenagers. At a March 18 lighting industry conference in Zhongshan, Zhao Shiling of Zhongke Rare Earth (Changchun) Co., Ltd. presented what the company calls a “rare-earth photobiological axial-inhibition technology,” based on a decade of research by the Chinese Academy of Sciences. In plain English: the company claims that specially engineered lighting—using rare earth luminescent materials to produce a targeted light spectrum—may help “put the brakes” on excessive eye-axis growth, a major structural driver of myopia.

From Lab Monkeys to Classroom Lights

According to the report, the core idea is to use a specific B/M spectrum generated by special rare-earth phosphor materials. Zhao said the research was conducted over ten years using juvenile macaques as an animal model, with findings published in the journal Zoological Research. The reported result is that low-color-temperature artificial light at 3000K significantly slowed eye-axis elongation in young monkeys.

For an American business audience, that matters because it shifts the discussion from generic “eye-care lamps” to a more specific, research-backed health-lighting claim. If validated, the technology could support premium lighting products positioned around pediatric eye health—a potentially large commercial category in China and beyond.

The Claimed Breakthrough: Lighting as a Health Intervention

The company says the technology has already been turned into a new type of “eye-protection” lamp and is being tested in multiple schools. Early application data reportedly show that it can reduce the rate of worsening myopia among students.

That is the business-news hook: this is not being framed as a concept-stage lab project, but as a technology moving from research to school-based deployment. It also reflects a broader Chinese push to combine rare earth materials science with consumer health applications, extending the value story for rare earths beyond magnets, EVs, and defense.

Why the West Should Pay Attention—Carefully

For the West, the significance is not a proven medical breakthrough, at least not yet. The bigger takeaway is that China is exploring higher-value downstream uses for rare earth materials in health-oriented products. A sector ripe for innovation and disruption based on the ongoing research and development programs tied to the materials. 

Still, major questions remain: the report gives no school trial size, no control-arm details, no peer-reviewed human outcomes, and no long-term safety or efficacy data.

Source Disclaimer: This item originates from Chinese state-linked and industry-affiliated media, including the China Rare Earth Industry Association and related Chinese outlets. The claims should be independently verified, particularly the technology's clinical relevance, commercial performance, and real-world efficacy.